10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial.

Meier RM, Aghdam N, Beckman AC, Woodhouse SA, Williamson SK, Mohideen N, Dombrowski JJ, Kaplan ID

Open source

DOI
10.1016/j.eururo.2026.04.029
Published
2026 May 8
Container
European urology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eururo.2026.04.029,
  title = {10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial.},
  author = {Meier RM and Aghdam N and Beckman AC and Woodhouse SA and Williamson SK and Mohideen N and Dombrowski JJ and Kaplan ID},
  year = {2026},
  journal = {European urology},
  doi = {10.1016/j.eururo.2026.04.029},
  url = {https://doi.org/10.1016/j.eururo.2026.04.029}
}

RIS

TY  - JOUR
TI  - 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial.
AU  - Meier RM
AU  - Aghdam N
AU  - Beckman AC
AU  - Woodhouse SA
AU  - Williamson SK
AU  - Mohideen N
AU  - Dombrowski JJ
AU  - Kaplan ID
PY  - 2026
JO  - European urology
DO  - 10.1016/j.eururo.2026.04.029
UR  - https://doi.org/10.1016/j.eururo.2026.04.029
ER  - 

APA

RM, M., N, A., AC, B., SA, W., SK, W., N, M., JJ, D., & ID, K. (2026). 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial.. European urology. https://doi.org/10.1016/j.eururo.2026.04.029

Source records